Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
α4 Integrin blockade impairs CD8+ T cell neuroimmune surveillance following SIV infection
Pabitra B. Pal, Sonny R. Elizaldi, Giovanne B. Diniz, Ravi Prakash Rai, Yashavanth Shaan Lakshmanappa, Anil Verma, Daniel Rossmiller, Jesse Kaufman, Rahul Srivastava, Sean Ott, Carissa T. Erices, Kayla Schwartz, Danielle Beckman, Zhong-Min Ma, Alex Petkov, Daniel Newhouse, Dhivyaa Rajasundaram, John H. Morrison, Reben Raeman, Smita S. Iyer
Pabitra B. Pal, Sonny R. Elizaldi, Giovanne B. Diniz, Ravi Prakash Rai, Yashavanth Shaan Lakshmanappa, Anil Verma, Daniel Rossmiller, Jesse Kaufman, Rahul Srivastava, Sean Ott, Carissa T. Erices, Kayla Schwartz, Danielle Beckman, Zhong-Min Ma, Alex Petkov, Daniel Newhouse, Dhivyaa Rajasundaram, John H. Morrison, Reben Raeman, Smita S. Iyer
View: Text | PDF
Research Article AIDS/HIV Immunology

α4 Integrin blockade impairs CD8+ T cell neuroimmune surveillance following SIV infection

  • Text
  • PDF
Abstract

Integrin-targeted therapies are under investigation for HIV-associated neuroinflammation, yet their effect on CNS antiviral immunity remains undefined. We examined the role of α4 integrin in T cell–mediated neuroimmune surveillance using SIV-infected macaques with α4 blockade and T cell–specific α4-deficient mice. In macaques, α4 blockade preserved CD4+ Th1 cell access to the brain parenchyma but impaired CD8 effector recruitment, disrupting antiviral control. Despite stable cerebrospinal fluid viral loads, hippocampal SIV RNA increased under blockade. Single-cell analyses revealed α4 enrichment in CD8 effector memory (Tem) cells; blockade reduced inferred CD8+ Tem-monocyte interactions and heightened innate immune activation in the hippocampus. Microscopy demonstrated persistent SIV-induced microglial simplification despite treatment. Th1 CD4 effectors correlated positively with gray matter viral RNA, whereas α4β7+ CD8+ T cells correlated inversely, implicating impaired CD8+ Tem recruitment in elevated parenchymal viral burden. In mice, α4 proved dispensable for CD4 trafficking to inflamed brain but essential for CD8 effector access across CNS compartments and for both subsets to reach skull marrow. These findings establish that α4 integrin governs CD8-mediated neuroimmune surveillance through coordinated cellular positioning, with blockade enabling viral seeding while disrupting spatially organized antiviral defense.

Authors

Pabitra B. Pal, Sonny R. Elizaldi, Giovanne B. Diniz, Ravi Prakash Rai, Yashavanth Shaan Lakshmanappa, Anil Verma, Daniel Rossmiller, Jesse Kaufman, Rahul Srivastava, Sean Ott, Carissa T. Erices, Kayla Schwartz, Danielle Beckman, Zhong-Min Ma, Alex Petkov, Daniel Newhouse, Dhivyaa Rajasundaram, John H. Morrison, Reben Raeman, Smita S. Iyer

×

Figure 3

Neuroimmune activation and spatial immune organization in prefrontal cortex and hippocampus following α4 blockade.

Options: View larger image (or click on image) Download as PowerPoint
Neuroimmune activation and spatial immune organization in prefrontal cor...
(A) Spatial transcriptomic workflow. RNAscope identified SIV RNA+ regions in prefrontal cortex (PFC) and hippocampus (Hp), guiding region of interest (ROI) selection for NanoString whole-transcriptome analysis (WTA). (B) Representative spatial deconvolution of SIV+ PFC ROI using a scRNA-seq–derived CD45+ brain reference. (C) Violin plots of immune subsets in SIV+ ROIs. α4-treated animals show reduced Tcm cells in PFC and Hp, with increased CD8+ Tem cells and monocytes in Hp versus IgG-treated animals. (D) Heatmap of differentially expressed genes across SIV+ and SIV– PFC ROIs from α4-treated animals (P < 0.05, |log2FC| > 0.5). (E) CellChat ligand-receptor interactions in SIV– PFC and Hp ROIs from α4-treated animals. (F) Volcano plot of pathway differences in PFC comparing α4-treated and IgG-treated groups. (G) Heatmap of top upregulated pathways in SIV+ Hp ROIs comparing α4-treated and IgG-treated animals. (H–L) RNAscope detection of SIV RNA in brain parenchyma and perivascular regions. Representative PFC images show SIV RNA+ signal (cyan) and CD3+ T cells (red). Yellow arrow indicates CD3+ SIV RNA+ cell; cyan arrowheads indicate SIV RNA+ cells near perivascular spaces. Magnified views of H and J on the left are shown in I and K. Scale bars: 50 μm (H, J, and L); 20 μm (I and K). (M) SIV RNA+ cells per cm² in PFC and Hp (mean ± SD). *P < 0.05, 2-tailed Welch’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts